About
Miniaturized, sustained-release drug delivery products
Areas of Focus
Categories
Drug Delivery & FormulationBoston & New England
Clinical Trials (18)
View allTotal Trials
18
As Lead Sponsor
17
As Collaborator
1
Total Enrollment
2,406
By Phase
PHASE3: 8PHASE2: 6PHASE4: 2PHASE1: 1
By Status
COMPLETED: 11ACTIVE_NOT_RECRUITING: 2WITHDRAWN: 2TERMINATED: 2RECRUITING: 1
Clinical Trials Pipeline18 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06683742Lead Sponsor
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56
PHASE3Active, not recruiting
400 participants
Started: Nov 27, 2024 · Completed: Oct 31, 2027
NCT06668064Lead Sponsor
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56
PHASE3Active, not recruiting
400 participants
Started: Oct 22, 2024 · Completed: Aug 31, 2027
NCT06099184Lead Sponsor
Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)
PHASE2Completed
27 participants
Started: Jan 15, 2024 · Completed: Oct 24, 2024
NCT05550350Lead Sponsor
A Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract Surgery
PHASE3Withdrawn
Started: Sep 30, 2022 · Completed: Sep 30, 2023
NCT05550363Lead Sponsor
A Study to Evaluate the Efficacy and Safety of DEXYCU® for the Treatment of Ocular Pain Associated With Cataract Surgery (2)
PHASE3Withdrawn
Started: Sep 30, 2022 · Completed: Sep 30, 2023
Locations (1)
Headquarters
Watertown, MA, United States
Map
Loading map...